Versant Capital Management, Inc Neogenomics Inc Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 699 shares of NEO stock, worth $4,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
699
Previous 2,306
69.69%
Holding current value
$4,487
Previous $22,000
77.27%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$91.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$43.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$38.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$36.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $808M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...